10 Mar 2020

(227 votes)

One-Week Rigvir Therapy In Germany: Get Cost Estimates Of Your Case Within 1-2 Days

The clinic has been operating for more than 15 years. About 3,000 patients have already been successfully treated from solid tumors

If you’ve been cancer clean after chemo, radio, or surgery, but then the disease returned or conventional methods didn't stop the cancer. This is what makes people look for alternatives and request the Rigvir® treatment details. With tumors removed, metastases may still keep spreading to the liver or other body organs. It is true especially for its advanced phases (stages III and IV).

Every cancer case is individual. And sometimes observing the diagnosis on the list of cancers that are vulnerable to some kind of treatment isn’t a synonym for having potentially successful treatment.

Therefore, to find out whether a patient can really benefit from Rigvir® in the German clinic, there is a need to pass a case evaluation. If the medical team at the clinic in Germnay decides a patient can be qualified as a candidate for Rigvir therapy, there is a 7-day program including:

  • Rigvir® shots catered specifically to the individual health needs
  • Daily consultations with the treating oncologists to monitor your progress and adjust your treatment plan if needed
  • Extra therapies to boost your immune system: thymus peptide injections, mistletoe therapies
  • Meals tailored to the current health condition
  • Accommodation at the clinic
  • Transfers to and from Munich International Airport (1,5-hour drive to the clinic)
  • Follow-up treatment plan

If you or the one close to you would like to qualify for Rigvir® therapy in Germany, click the button below.

Scenic Clinic View and Rigvir Treatment


Although Rigvir® Was Originally Used To Fight Melanoma, Off-Label Use Showed It Can Fight A Range Of Cancer Types

Rigvir® isn’t a magic pill. Not even close to it.

Rigvir can help treat solid tumors only (having no effect on leukemia, lymphoma, and myeloma, also known as liquid malignant tumors)

Patient should be more than 18 years old to qualify for Rigvir

And if we stick to dry facts, officially the drug improves the survival rates in melanoma patients only. However, real-life experience shows there’s much more to it than just treating melanoma. This information was gathered through a range of medical research, performed from 1968 until today.

According to Acta Medica Lituanica, a medical journal (year 2002):

  • The three-year survival rate for patients with melanoma treated with surgery alone was 46-58%. Melanoma patients who received Rigvir® therapy showed a three-year survival rate of 57-84% and a five-year survival rate of 44-66%.
  • The three- and five-year survival rates for patients with ocular melanoma were 90% and 70%, respectively
  • The five-year survival rate for patients with stage III stomach cancer after surgery alone was 24-33%. Patients with the same diagnosis who completed Rigvir® treatment showed 47-60% survival rate.
  • The five-year survival rate for patients with stage II-IV rectal cancer after surgery alone was 41-68%. Patients with the same diagnosis who completed Rigvir® treatment showed 71-78%.

According to Melanoma Research, a peer-reviewed medical journal (October 2015):

According to APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica), a medical journal (July 2016):


If you or the one close to you would like to qualify for Rigvir® therapy in Germany, click the button below.

Patients from roughly 25 countries around the world have started using Rigvir® to treat:

  • Melanoma
  • Lung cancer
  • Various types of sarcoma
  • Neuroendocrine tumors
  • Glioblastoma
  • Ovarian cancer
  • Uterine cancer
  • Breast cancer
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Pancreatic cancer
  • Colorectal cance

Rigvir® Therapy Causes Slight Increase Of Body Temperature And Can Be Combined With Conventional Methods For Cancer Treatment

We understand that you still have questions about how safe is Rigvir®. To receive your answers, fill out the form on the right so the patient coordinator will get back to you in less than 24 hours.

But if there’s one thing you should take from this article about the safety of Rigvir®, it’s that the only side effect registered so far is a slight increase in body temperature (up to 99.5°F/37.5°C) that disappears in three days.

Another patient-friendly feature of the medicine is that it is not multiplying itself outside the malignant cell. This means that Rigvir® leaves healthy tissues surrounding the tumor safe.

It is possible to apply Rigvir® cancer treatment additionally to the conventional methods like chemotherapy or radiotherapy or use it alone.

In Germany, The Oncologists Will Track How Well Your Body Responses To Rigvir® And Immediately Introduce Appropriate Changes If Needed

Before we answer your questions about how safe Rigvir® therapy is, let’s take a closer look at the venue.

If flying to Germany isn’t an obstacle, you will be undergoing treatment at the clinic of integrative medicine situated close to Munich in Germany and Innsbruck in Austria. Everybody speaks English here, starting from the driver who meets you at the airport to the oncologist with whom you will have daily consultations.

The Rigvir® injections will be administered by a nurse after the skin test to check if you aren’t allergic to the drug. In case you are, the injection (2 mL = 0.07 oz) may be split into parts and taken together with immunosuppressant drugs.


Please fill in the form on the right if you are looking for:

  • a free medical opinion for you or someone close to you
  • a Rigvir Package and follow-up treatment
  • other information about Rigvir

We will contact you within 24 hours including Saturdays, Sundays, and holidays to put you through to the relevant patient coordinator at the clinic. Please note that the price tag of the program is constant no matter who you contact first — International Medical Tourism Center or the clinic.

P.S. Please note that Rigvir® has never been a panacea. If based on your medical files you can’t benefit from using Rigvir®, the medical team will inform you immediately.

If you would like to read the article in your own language, i.e. Polska, Italia, Deutschland, please use Google Translate.

List of References

  1. Brūvere, R., O., Heisele A. Ferdats, A. Rupais, and A. Muceniece, Echovirus-mediated biotherapy for malignant tumours: 40 years of investigation. Acta medica Lituanica, 2002. Suppl. 9: p. 97-100.
  2. “Adapted ECHO-7 Virus RigVir Immunotherapy (oncolytic Virotherapy) Prolongs Survival in Melanoma Patients after Surgical Excision of the Tumour in a Retrospective Study.” Doniņa, Simona; Strēle, Ieva; Proboka, Guna; Auziņš, Jurgis; Alberts, Pēteris; Jonsson, Björn; Venskus, Dite; Muceniece, Aina. Melanoma Research: October 2015 - Volume 25 - Issue 5 - p 421–426.
  3. Alberts, P., E. Olmane, L. Brokāne, Z. Krastiņa, M. Romanovska, K. Kupčs, S. Isajevs, G. Proboka, R. Erdmanis, J. Nazarovs, and D. Venskus, Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports. APMIS, 2016. 124(10): p. 896-904.